The JSE was weaker on Thursday, along with its global counterparts, as Covid-19 vaccine hopes were dampened by concerns over US-China tension and rising infection numbers.

The dispute between the US and China over control of advanced technologies continues to weigh on investor risk appetite, while  a resurgence of Covid-19 in some economies is triggering implementation of restrictions on business activity that may threaten economic growth...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.